1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NEI Small Business Innovative Research (SBIR) (R43/R44) and Small Business Technology Transfer Research (STTR) (R41/R42) programs is sponsored by National Eye Institute (NEI) / National Institutes of Health (NIH).
The NEI SBIR and STTR programs provide early-stage capital for innovative small U.S. companies to engage in federal Research & Development (R&D) that has strong potential for commercialization, focusing on research to understand visual function and eye diseases.
This includes projects that develop commercial products to help solve problems of eye disease or visual dysfunction, which could encompass bioelectronic solutions for vision restoration.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organized for-profit U.S. businesses, at least 51% U.S.-owned by individuals and independently operated, with 500 or fewer employees. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: up to $295,924; Phase II: up to $1,972,828. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NEI Small Business Innovative Research (SBIR) (R43/R44) and Small Business Technology Transfer Research (STTR) (R41/R42) programs is funded by National Eye Institute (NEI) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article